Search results
Cervical Cancer Screening Study Points to Potential for DNA Methylation-Based Triage Strategy
GenomeWeb News· 8 hours agoThe methylation-based WID-qCIN test, used in combination with HPV data, appeared to outperform cytology testing for detecting cervical cancer and high-risk precancerous lesions.
Bodyguard, bank, vaccine critic: RFK Jr.'s celebrity protector plays a key campaign role
NBC NEWS· 16 hours agoIn January, some of Robert F. Kennedy Jr.’s closest supporters gathered at the tony London Hotel in...
Promising HPV Cancer Treatment Advances in Clinical Trial By Investing.com
Investing.com· 7 hours agoHOOKIPA Pharma Inc. (NASDAQ: HOOK), a clinical-stage biopharmaceutical company, has reported...
Boys Need the HPV Cancer Vaccine as Much as Girls
Bloomberg· 2 days agoLisa Jarvis is a Bloomberg Opinion columnist covering biotech, health care and the pharmaceutical industry. Previously, she was executive editor of...
At-school vaccination boosts HPV vaccination coverage
Medical Xpress· 5 days agoAt-school vaccination may be a useful tool to increase human papillomavirus (HPV) vaccination...
Gonorrhoea cases reach record high in England
BBC via Yahoo News· 8 hours agoBut the number of chlamydia cases remained stable compared with 2022 and fell compared with 2014. Cases of genital warts continued to fall, which is...
Sponsored: New screening guidelines don’t change need for doctor visits
The Grass Valley Union· 9 hours agoIn the past several years, much has changed in regard to preventive screenings and women’s health,...
How to Identify and Treat Warts, According to Doctors
PopSugar· 12 hours agoThere are so many skin concerns that are easy to diagnose yet hard to treat, including warts. If you...
Gonorrhoea cases reach record high in England
BBC News· 8 hours agoA record number of people in England were diagnosed with gonorrhoea last year, annual UK Health Security Agency figures show. Overall, sexually...
ASCO: Proton therapy demonstrates advantages in Ph | Newswise
Newswise· 2 days agoCHICAGO ― According to preliminary data from a multi-institution Phase III trial led by researchers at The University of Texas MD Anderson Cancer Center, intensity modulated proton therapy ( ...